Sinopharm Group Co. Ltd.

SHTDY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$54,313$63,809$55,222$43,529
Short-Term Investments$0$1$0$12
Receivables$206,721$185,790$171,204$172,576
Inventory$62,353$60,028$60,926$51,500
Other Curr. Assets$24,060$27,208$32,054$23,306
Total Curr. Assets$347,448$336,835$319,406$290,922
Property Plant & Equip (Net)$19,632$19,898$17,792$17,598
Goodwill$6,252$7,186$7,156$7,199
Intangibles$4,718$2,830$4,870$5,003
Long-Term Investments$10,894$10,551$9,840$9,173
Tax Assets$2,408$0$1,980$1,787
Other NC Assets$1,479$6,095$3,731$3,731
Total NC Assets$45,384$46,560$45,369$44,490
Other Assets$0$0$0$0
Total Assets$392,831$383,395$364,775$335,412
Liabilities
Payables$156,870$154,747$144,617$132,867
Short-Term Debt$64,490$56,527$54,633$56,700
Tax Payable$0$2,989$3,279$3,008
Deferred Revenue$0$0$0$21,620
Other Curr. Liab.$29,016$27,228$32,434$5,111
Total Curr. Liab.$250,376$241,491$234,963$219,307
LT Debt$11,897$17,255$14,957$11,669
Deferred Rev, NC$0$448$494$463
Deferred Tax Liab, NC$0$788$937$1,023
Other NC Liab.$3,872$3,094$3,355$3,298
Total NC Liab.$15,768$21,585$19,743$16,452
Other Liabilities$0$0$0$0
Cap. Leases$5,020$5,217$4,843$4,798
Total Liabilities$266,144$263,076$254,706$235,758
Equity
Pref Stock$0$0$4,391$0
Common Stock$3,121$3,121$3,121$3,121
Retained Earnings$53,745$49,410$42,870$38,516
AOCI$22,022$0-$4,391-$4,388
Other Equity-$4$22,052$22,034$24,638
Total Equity$78,884$74,582$68,069$61,886
Supplemental Information
Minority Interest$47,804$45,737$42,001$37,768
Total Liab. & Tot. Equity$392,831$383,395$364,775$335,412
Net Debt$22,073$9,973$14,369$24,839